Business Description
First Wave BioPharma Inc
NAICS : 325412
SIC : 2834
ISIN : US05502L1052
Description
First Wave BioPharma Inc is a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases. It is advancing a therapeutic development pipeline populated with multiple clinical-stage programs built around its two proprietary technologies-niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties, and the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.49 | |||||
| Equity-to-Asset | 0.52 | |||||
| Debt-to-Equity | 0.23 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 87.9 | |||||
| 3-Year EPS without NRI Growth Rate | 74.9 | |||||
| 3-Year FCF Growth Rate | 84.9 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.37 | |||||
| 9-Day RSI | 36.94 | |||||
| 14-Day RSI | 36.3 | |||||
| 6-1 Month Momentum % | -26.33 | |||||
| 12-1 Month Momentum % | -92.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.58 | |||||
| Quick Ratio | 1.58 | |||||
| Cash Ratio | 1.18 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1182.5 | |||||
| Shareholder Yield % | -257.67 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -597.44 | |||||
| ROA % | -280.93 | |||||
| ROIC % | -655.43 | |||||
| ROC (Joel Greenblatt) % | -5522.76 | |||||
| ROCE % | -558.22 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.18 | |||||
| Price-to-Tangible-Book | 2.22 | |||||
| EV-to-EBIT | -0.2 | |||||
| EV-to-EBITDA | -0.21 | |||||
| EV-to-Forward-Revenue | -64.47 | |||||
| EV-to-FCF | -0.26 | |||||
| Price-to-Net-Current-Asset-Value | 2.55 | |||||
| Price-to-Net-Cash | 9.75 | |||||
| Earnings Yield (Greenblatt) % | -500 | |||||
| FCF Yield % | -223.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:FWBI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
First Wave BioPharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -304.477 | ||
| Beta | 1.18 | ||
| Volatility % | 111.74 | ||
| 14-Day RSI | 36.3 | ||
| 14-Day ATR ($) | 0.454291 | ||
| 20-Day SMA ($) | 3.497495 | ||
| 12-1 Month Momentum % | -92.04 | ||
| 52-Week Range ($) | 2.42 - 64.998 | ||
| Shares Outstanding (Mil) | 2.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
First Wave BioPharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
First Wave BioPharma Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
First Wave BioPharma Inc Frequently Asked Questions
What is First Wave BioPharma Inc(FWBI)'s stock price today?
The current price of FWBI is $2.73. The 52 week high of FWBI is $65.00 and 52 week low is $2.42.
When is next earnings date of First Wave BioPharma Inc(FWBI)?
The next earnings date of First Wave BioPharma Inc(FWBI) is 2024-05-10 Est..
Does First Wave BioPharma Inc(FWBI) pay dividends? If so, how much?
First Wave BioPharma Inc(FWBI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers